James T. Rosenbaum, M.D. Physician · Scientist · Essayist

Four decades at the intersection of the eye and the immune system.

One of the world's foremost authorities on uveitis and ocular inflammatory disease — clinician, NIH-funded investigator, teacher, essayist, and author of a children's book about a giraffe and an elephant. He is the founder of The Rheumy Eyes, an international organization for rheumatologists with a major interest in ocular inflammatory diseases.

Portrait of James T. Rosenbaum, M.D.
  • 1stIn the world for impact on uveitis, ExpertScape, every year 2013–2024
  • ~700Scientific papers and book chapters
  • 46,000+Citations; h-index 105 (Google Scholar)
  • 41Consecutive years of NIH funding as a principal investigator

Contributions to science

Work that changed how inflammatory eye disease is understood, named, and treated.

A new model of uveitis

Description of a novel model of uveitis in rats — endotoxin-induced uveitis — published in Nature in 1980 and still in use as a model for human disease.

The microbiome and HLA-B27

Pioneering studies on the microbiome and its relationship to ankylosing spondylitis and acute anterior uveitis.

A shared vocabulary

Co-organizer of the international panels that set the standards the field uses: SUN for uveitis nomenclature, FOCUS for uveitis therapy, and ReViSe for retinal vasculitis.

Biologics for the eye

Author of some of the first reports on biologic therapy for uveitis and scleritis, and international co-chair of the landmark immunosuppression guidelines.

Molecular diagnosis

Novel descriptions of transcriptomic diagnosis for sarcoidosis and other forms of uveitis and orbital inflammatory disease.

Teaching a generation

Mentees now lead programs at Duke, UCSD, Rochester, Yale, Oxford, Harvard, OHSU, Melbourne, and Flinders.

Speaking

Dr. Rosenbaum lectures internationally. Recent and forthcoming named lectureships include the Bajandas Lectureship at the University of Texas, San Antonio, and the Patrick Mroczkowski Memorial Grand Rounds at Albany Medical Center. His next scheduled appearance is a Meet the Professor session at the American College of Rheumatology Annual Meeting in November 2026.